# Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease

> **NCT02454426** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Thomas Jefferson University**

## Conditions studied

- Major Depressive Disorder
- Coronary Artery Disease

## Interventions

- **DRUG:** Vortioxetine

## Key facts

- **NCT ID:** NCT02454426
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left institution
- **Last updated:** 2016-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02454426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02454426, "Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02454426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*